235 related articles for article (PubMed ID: 21524885)
21. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome.
Blank M; Krause I; Magrini L; Spina G; Kalil J; Jacobsen S; Thiesen HJ; Cunningham MW; Guilherme L; Shoenfeld Y
Rheumatology (Oxford); 2006 Jul; 45(7):833-41. PubMed ID: 16705050
[TBL] [Abstract][Full Text] [Related]
22. Tolerogenic dendritic cells specific for β2-glycoprotein-I Domain-I, attenuate experimental antiphospholipid syndrome.
Zandman-Goddard G; Pierangeli SS; Gertel S; Blank M
J Autoimmun; 2014 Nov; 54():72-80. PubMed ID: 24972993
[TBL] [Abstract][Full Text] [Related]
23. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein.
Tzang BS; Lee YJ; Yang TP; Tsay GJ; Shi JY; Tsai CC; Hsu TC
Clin Chim Acta; 2007 Jul; 382(1-2):31-6. PubMed ID: 17451664
[TBL] [Abstract][Full Text] [Related]
24. The Effects of NF-κB and c-Jun/AP-1 on the Expression of Prothrombotic and Proinflammatory Molecules Induced by Anti-β2GPI in Mouse.
Xia L; Xie H; Yu Y; Zhou H; Wang T; Yan J
PLoS One; 2016; 11(2):e0147958. PubMed ID: 26829121
[TBL] [Abstract][Full Text] [Related]
25. In vitro effects of antiphospholipid syndrome-IgG fractions and human monoclonal antiphospholipid IgG antibody on human umbilical vein endothelial cells and monocytes.
Clemens N; Frauenknecht K; Katzav A; Sommer C; von Landenberg P
Ann N Y Acad Sci; 2009 Sep; 1173():805-13. PubMed ID: 19758232
[TBL] [Abstract][Full Text] [Related]
26. Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies.
Atsumi T; Amengual O; Yasuda S; Matsuura E; Koike T
Autoimmunity; 2005 Aug; 38(5):377-81. PubMed ID: 16227153
[TBL] [Abstract][Full Text] [Related]
27. β2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis.
Raschi E; Chighizola CB; Grossi C; Ronda N; Gatti R; Meroni PL; Borghi MO
J Autoimmun; 2014 Dec; 55():42-50. PubMed ID: 24685231
[TBL] [Abstract][Full Text] [Related]
28. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.
Redecha P; Franzke CW; Ruf W; Mackman N; Girardi G
J Clin Invest; 2008 Oct; 118(10):3453-61. PubMed ID: 18802482
[TBL] [Abstract][Full Text] [Related]
29. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro.
Di Simone N; Raschi E; Testoni C; Castellani R; D'Asta M; Shi T; Krilis SA; Caruso A; Meroni PL
Ann Rheum Dis; 2005 Mar; 64(3):462-7. PubMed ID: 15256379
[TBL] [Abstract][Full Text] [Related]
30. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies.
Vega-Ostertag M; Casper K; Swerlick R; Ferrara D; Harris EN; Pierangeli SS
Arthritis Rheum; 2005 May; 52(5):1545-54. PubMed ID: 15880836
[TBL] [Abstract][Full Text] [Related]
31. Activation of MAPKs in the anti-β2GPI/β2GPI-induced tissue factor expression through TLR4/IRAKs pathway in THP-1 cells.
Zhou H; Chen D; Xie H; Xia L; Wang T; Yuan W; Yan J
Thromb Res; 2012 Oct; 130(4):e229-35. PubMed ID: 22940059
[TBL] [Abstract][Full Text] [Related]
32. Anti-beta2-glycoprotein I antibodies recognizing platelet factor 4-heparin complex in antiphospholipid syndrome in patient substantiated with mouse model.
Bourhim M; Darnige L; Legallais C; Arvieux J; Cevallos R; Pouplard C; Vijayalakshmi MA
J Mol Recognit; 2003; 16(3):125-30. PubMed ID: 12833567
[TBL] [Abstract][Full Text] [Related]
33. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation.
Adams M
Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304
[TBL] [Abstract][Full Text] [Related]
34. Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations.
Blank M; Shoenfeld Y
Clin Immunol; 2004 Aug; 112(2):190-9. PubMed ID: 15240163
[TBL] [Abstract][Full Text] [Related]
35. Phospholipid-bound beta 2-glycoprotein I induces the production of anti-phospholipid antibodies.
Subang R; Levine JS; Janoff AS; Davidson SM; Taraschi TF; Koike T; Minchey SR; Whiteside M; Tannenbaum M; Rauch J
J Autoimmun; 2000 Aug; 15(1):21-32. PubMed ID: 10936025
[TBL] [Abstract][Full Text] [Related]
36. A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells.
Vega-Ostertag M; Liu X; Kwan-Ki H; Chen P; Pierangeli S
Br J Haematol; 2006 Oct; 135(2):214-9. PubMed ID: 16965389
[TBL] [Abstract][Full Text] [Related]
37. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides.
Blank M; Shoenfeld Y; Cabilly S; Heldman Y; Fridkin M; Katchalski-Katzir E
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5164-8. PubMed ID: 10220436
[TBL] [Abstract][Full Text] [Related]
38. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
39. T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals.
Hattori N; Kuwana M; Kaburaki J; Mimori T; Ikeda Y; Kawakami Y
Arthritis Rheum; 2000 Jan; 43(1):65-75. PubMed ID: 10643701
[TBL] [Abstract][Full Text] [Related]
40. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway.
López-Pedrera C; Buendía P; Cuadrado MJ; Siendones E; Aguirre MA; Barbarroja N; Montiel-Duarte C; Torres A; Khamashta M; Velasco F
Arthritis Rheum; 2006 Jan; 54(1):301-11. PubMed ID: 16385547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
